Anzeige
Mehr »
Dienstag, 13.05.2025 - Börsentäglich über 12.000 News
Titan für Raketen, Vanadium für Batterien: Radar-Projekt perfekt für die Industrie-Revolution!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
240 Leser
Artikel bewerten:
(1)

JPA Health Expands Global Presence with Acquisition of Award-Winning akt health communications, based in London

Finanznachrichten News

WASHINGTON, July 22, 2024 /PRNewswire/ -- JPA Health, an independent, full-service agency working exclusively in the health sector, announced the acquisition of London-based akt health, an award-winning communications agency recognized for its work in delivering excellence across public relations, medical education and patient engagement programs.

JPA Health logo (PRNewsfoto/JPA HEALTH COMMUNICATIONS)

"We are delighted to welcome akt health into the growing network at JPA Health," said Carrie Jones, CEO of JPA Health. "The company's accomplished leadership team shares our core values and commitment to exceptional client service. While JPA Health has a strong track record supporting U.S. and global clients, we recognize the increasing importance of the European market to our clients' businesses. Akt health's deep understanding of these market complexities will be a valuable addition, enhancing our ability to deliver impactful healthcare solutions on a global scale."

Founded in 2018 by Anna Radnavale, Katy Foy and Tim Cockroft, akt health offers a bespoke service to healthcare clients, motivated by a central mission to make the world a healthier place while improving and protecting lives. The team has received global recognition for their work across Diversity & Inclusion Communications, Healthcare PR, Digital and Multichannel Communications.

"At the heart of this integration are shared values and a belief that, together, we can create work that truly transforms lives," said Tim Cockroft, Executive Director, akt health. "We are hugely excited to be welcomed into the JPA Health family and to bring a new depth of European and UK expertise to this growing team. JPA and akt are both deeply committed to excellence in client service and fostering an agency culture that values its people. Through this alliance, we look forward to offering enhanced capabilities, passion and unrivaled creativity to our clients."

The acquisition of akt health is JPA's third transaction following the recent additions of medical communications firm BioCentric, a medical communications agency based in greater Philadelphia and AI-driven strategic solutions consultancy, True North Solutions, based in Cambridge, Mass. Together, JPA Health offers clients an exceptional pool of talent, equipped to meet our current and future clients' needs across the Life Sciences, Public Health, One Health, and Federal Government sectors.

The founders will join JPA Health as Executive Directors, and all akt health employees will become part of JPA Health. The combined agency now has nearly 150 employees worldwide with offices in the U.S. and Europe (UK, Switzerland), offering a synergistic suite of services that includes corporate communications, brand marketing, patient engagement, and scientific storytelling.

JPA Health
JPA Health is an award-winning independent, full-service agency established in 2007. With offices across the U.S. and Europe, the agency seamlessly brings together flexible solutions in public relations, commercial marketing, patient advocacy, and medical communications across the health sector. Leveraging tailored AI solutions, JPA Health crafts seamless, 360-degree omnichannel strategies to engage healthcare stakeholders effectively. As a women-owned and independent agency, we are passionate about helping people live healthier lives and dedicated to pushing the boundaries of healthcare communications. Discover more at www.jpa.com.

akt health - A JPA Health Company
Based in central London, akt health supports clients with UK and EU strategic healthcare communications. Working alongside life science clients, akt health looks to enable Better Health for All by igniting conversation, transforming practice and driving patient engagement. The agency has a particular passion for addressing areas of health inequities through its campaign work and in 2023 was named PR Week UK's health and pharma agency of the year. Founded in 2018, akt health joined JPA Health in July 2024.

Logo - https://mma.prnewswire.com/media/1941041/JPA_Health_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/jpa-health-expands-global-presence-with-acquisition-of-award-winning-akt-health-communications-based-in-london-302202005.html

© 2024 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.